New roles of endothelial regrowth in ischemic tissue recovery and regeneration

Project: Research project

Project Details

Description

Tissue regeneration and repair is essential for maintaining physiological homeostasis and relies on the precise control of molecular networks that regulate, or are regulated by, the vasculature. Endothelial cells (ECs) present in the blood and lymphatic vessels (i.e., BECs and LECs, respectively) are crucial participants in the vascular-dependent processes that restore damaged tissue, because they control the secretion of paracrine factors from both the vessels themselves and nearby cells. However, the mechanisms by which ECs govern the activity of other cellular components that participate in the recovery of injured tissues have yet to be adequately characterized. The long-term goal of our lab is to elucidate the fundamental processes that regulate blood- and lymphatic-vessel function and to understand how disruption of these mechanisms leads to pathological vascular defects. We have previously shown that in mice, global homozygous knockout mutations of Foxc1 and/or Foxc2 are associated with vascular anomalies; however, the mutations also lead to embryonic or perinatal lethality, so attempts to determine how the two Foxc genes function in adult animals have generally been inconclusive. To overcome this limitation, we generated a line of mice carrying tamoxifen-inducible, endothelial cell (EC)-specific, compound Foxc1;Foxc2 mutations (i.e., EC-Foxc-DKO mice), and the results from preliminary investigations with these animals indicate that the mutations impair regeneration of the small intestine after ischemia-reperfusion (I/R) injury by causing defects in (1) the regrowth of intestinal blood and lymphatic vessels, (2) the formation of subepithelial stromal cells (e.g., telocytes), (3) the expression of CXCL12 and R-spondin3 in intestinal BECs and LECs, respectively and (4) activation of the Wnt/-catenin pathway in intestinal stem cells (ISCs). CXCL12 is known to regulate angiogenesis, while R-spondin3 protects mice from vascular leakage, and the two factors cooperatively stimulate canonical Wnt/-catenin signaling, which subsequently regulates the proliferation of ISCs. Thus, our central hypothesis is that the transcriptional activity of Foxc1/c2 in BECs and LECs contributes to vascular repair and intestinal regeneration by regulating CXCL12 and R-spondin3 signaling. We will test our central hypothesis by pursuing the two Specific Aims: (1) To determine whether Foxc1 and Foxc2 are required for repair of the intestinal vasculature during recovery from intestinal injury, (2) To determine the mechanisms by which Foxc1 and Foxc2 regulate blood vessel recovery and intestinal regeneration, and (3) To determine whether Foxc1 and Foxc2 regulate lymphatic vessel recovery and intestinal regeneration. In summary, the experiments described in this proposal will provide crucial information about how Foxc1/c2 expression in vascular ECs contributes to intestinal repair and regeneration. Furthermore, since vascular deficiencies contribute to a variety of ischemic disorders, our findings may have important implications for other ischemic conditions that are associated with impairments in tissue regeneration, such as cardiovascular disease.
StatusActive
Effective start/end date4/1/223/31/26

Funding

  • National Heart, Lung, and Blood Institute (5R01HL159976-03)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.